Tildrakizumab

1 Drug classified under this active ingredient

Interleukin Inhibitor. Tildrakizumab 100 mg / 1 ml.
PREFILL. SYRINGE:100 mg 100 mg SC inj. at wks. 0, and 4, every 12 wks. thereafter.
Tmt. of adult. with mod.-sev. plaque psoriasis who are candidates for syst. ther. or photother.
C/I: Hypersens. Clinic. import. active infect., e.g. active tubercul.